Long-term outcomes of switching to BIC/FTC/TAF with or without prior INSTI experience: real-life data from a monocentric cohort of ART-experienced people with HIV
Key Points
The aim is to assess the long-term outcomes of switching to BIC/FTC/TAF in ART-experienced individuals with or without INSTI experience.
Monocentric cohort study design
Sample of ART-experienced individuals
Evaluation of switch outcomes over time
Assessment of safety and lipid profiles
BIC/FTC/TAF demonstrated durable efficacy and safety
The regimen was well tolerated by individuals without prior INSTI experience
Results indicate favorable lipid profiles when switching to BIC/FTC/TAF
Abstract
Our real-life data further support the role of BIC/FTC/TAF as a durable, safe and "lipid-friendly" ART switch option, also for PWH without prior INSTI experience.
Like
Bookmark
Share
Like
Bookmark
Share
Long-term outcomes of switching to BIC/FTC/TAF with or without prior INSTI experience: real-life data from a monocentric cohort of ART-experienced people with HIV | Synapse